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Abstract
Hepatitis is a general term meaning inflammation of the liver, which can be caused by a vari-
ety of viruses. However, a substantial number of cases remain with unknown aetiology. We
analysed the serum of patients with clinical signs of hepatitis using a metagenomics
approach to characterize their viral species composition. Four pools of patients with hepati-
tis without identified aetiological agents were evaluated. Additionally, one pool of patients
with hepatitis E (HEV) and pools of healthy volunteers were included as controls. A high
diversity of anelloviruses, including novel sequences, was found in pools from patients with
hepatitis of unknown aetiology. Moreover, viruses recently associated with gastroenteritis
as sapovirus GV.2 and astrovirus VA3 were also detected only in those pools. Besides,
most of the HEV genome was recovered from the HEV pool. Finally, GB virus C and human
endogenous retrovirus were found in the HEV and healthy pools. Our study provides an
overview of the virome in serum from hepatitis patients suggesting a potential role of these
viruses not previously described in cases of hepatitis. However, further epidemiologic stud-
ies are necessary to confirm their contribution to the development of hepatitis.
Introduction
Hepatitis is a general term meaning inflammation of the liver and can be caused by a variety of
viruses, such as hepatitis A, B, C, D and E [1]. Infectious agents such as bacteria, fungi or para-
sites, as well as non-infectious agents such as alcohol, drugs or autoimmune diseases, may
cause hepatitis too. According to the estimates of the Global Burden of Disease study, viral
hepatitis is responsible for approximately 1.5 million deaths each year, which is comparable to
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the number of annual deaths from HIV/AIDS (1.3 million), malaria and tuberculosis (TB) (0.9
million and 1.3 million, respectively) [2].
Viral hepatitis is still one of the key causes of acute liver failure (ALF) in the world. ALF is a
devastating clinical syndrome associated with high mortality in the absence of immediate care,
specific treatment or liver transplantation [3]. Globally, hepatitis A, B and E infections are
probably responsible for the majority of ALF cases. However, despite significant progress in
the diagnosis and treatment of hepatitis, in a considerable number of patients, the aetiological
agents remain unknown. Previous studies have found that between 3.8% and 33.9% of hospital
inpatients with acute hepatitis had non-A-E-hepatitis [4–8]. Additionally, 10% of patients with
ALF had non-A-E hepatitis [9].
Therapeutic trials using interferon-α to treat hepatitis of unknown aetiology have consis-
tently resulted in response rates of approximately 50%, indicating a virological aetiology [10].
This evidence suggests that other viruses may be responsible for hepatitis. As a result, new
viruses, including a Flaviviridae GB virus type C (GBV-C) [11] and Anelloviridae TTV and
SEN virus [12], have been reported in recent years to be associated with hepatitis. However,
epidemiological data failed to confirm a causative role for those viruses in the development of
hepatitis, and a high percentage of individuals infected by them were found to be healthy carri-
ers [13,14]. Recent investigation has shown that other viral infections such as cytomegalovirus
and Epstein Barr virus may mimic viral hepatitis [15]. Less frequently, hepatitis may be present
in people with herpes simplex virus [16], parvovirus B19 [17], and adenoviruses 1, 2, 5, 12 and
32 [18,19].
Epidemiologic information related to non-A-E hepatitis is scarce. In a study by Delic et al.
2010, analysing 408 patients with acute hepatitis, history of blood transfusion, drug use or
other parenteral exposure were not associated with the onset of illness [7], suggesting that if
the viral nature of non-A-E hepatitis is proven, it should spread primarily by non-parenteral
means. Moreover, some patients diagnosed with acute non-A-E hepatitis show biochemical
features at admission similar to those associated with other viral hepatitis. Apparently, acute
non-A-E hepatitis is distributed worldwide, and progression to chronicity was observed in
approximately 9% of patients [7,20].
The cause of acute non-A-E hepatitis remains unknown. It seems likely that another as-yet-
unidentified infectious agent(s) exists [20]. Recent rapid progress in sequencing technologies
and associated bioinformatics methodologies has enabled a more in-depth view of the struc-
ture and functioning of viral communities, supporting the characterization of emerging
viruses [21]. With the advent of metagenomics studies, our knowledge of the different compo-
nents and the complexity of the microbiome greatly expanded. The eukaryotic virome com-
prises viruses infecting the host, endogenous viral elements, and viruses associated with other
eukaryotic components of the ingesta [22].
In this study, next-generation sequencing (NGS) was used to identify viruses in serum sam-
ples from patients suffering from acute hepatitis signs. For that purpose, the viromes in the
serum of patients with Non-A-E hepatitis were analysed and the results were compared with
the viromes from patients with acute hepatitis E (positive controls) and healthy patients (nega-
tive controls).
Materials and methods
Serum samples
A total number of 42 serum samples were collected from patients with acute viral hepatitis
from the Vall d’Hebron Hospital, Barcelona, Spain. The clinical diagnosis of acute viral hepati-
tis was based on the lack of previous history of chronic liver disease, a rise in serum
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aminotransferase (AST, ALT) activity of at least 200 IU/L, high values of total (TB) and direct
bilirubin (DB) and exclusion of other causes of liver disease such as hepatitis A (Ig-M nega-
tive), hepatitis B (surface-antigen-HBsAg- and anti-core antibodies-anti-HBc-negative-), hep-
atitis C (anti-VHC-negative) and hepatitis E (HEV) (IgG, IgM and RT-PCR, all negatives). Of
the 32 patients with acute hepatitis of unknown aetiology, 19 were male, and 13 were female,
with ages ranging from one to 92 years old. Eight of those patients were diagnosed with an
autoimmune or immunosuppressed (Ai+ImSP) condition. Additionally, serum samples from
10 patients—positive for HEV by nested RT-PCR—were included as positive controls. In addi-
tion, serum samples from 20 healthy volunteers were also evaluated.
The serum samples were pooled according to the following criteria. Patients with acute hep-
atitis were grouped into five pools: male pool A (8 samples, age range from 1 to 44), male pool
B (8 samples, age range from 45 to 78), a female pool (8 samples, age range from 6 to 92), and
an Ai+ImSP pool (8 samples, age range from 2 to 84) that included patients with the Ai+ImSP
condition. Finally, a pool of HEV RNA-positive patients (10 samples, age range from 6 to 84)
was included. Healthy volunteers’ serum samples were grouped in two pools and evaluated in
duplicate: Healthy A1 and A2 pools, with 10 females (age range between 27 and 63), and
Healthy B1 and B2 pools, with 2 males and 8 females (age range between 26 and 58).
Sample preparation
Serum samples were kept at -80˚C prior to the metagenomics analysis protocol. Pools were
prepared with the corresponding serum samples to achieve an initial volume of 500 μL. Briefly,
the pools were first filtered through a pore size of 0.45 μm (Millipore Corp., Billerica, MA,
USA) to remove cellular debris, ultracentrifuged at 100,000 × g for 90 min at 4˚C and re-sus-
pended in 500 μL of PBS 1X. Next, 300 μL of the re-suspended pool was subjected to DNAse
treatment to eliminate background DNA with 20 U TURBO™ DNase (Ambion, Thermo Fisher
Scientific, Waltham, MA, USA). Then, viral nucleic acids (NAs) were extracted with QIAmp
Viral RNA Mini Kit (Qiagen, Inc., Valencia, CA), without carrier RNA, according to the man-
ufacturer‘s instructions. To enable the detection of both DNA and RNA viruses, total NAs
were reverse-transcribed as previously described [23,24]. In short, SuperScript II (Life Tech-
nologies, California, USA) was used to retro-transcribe RNA to cDNA with primerA (5’-
GTTTCCCAGTCACGATCNNNNNNNNN-3’). Second-strand cDNA and DNA were con-
structed with the primer sequences using Sequenase 2.0 (USB/Affymetrix, Cleveland, OH,
USA). PCR amplification with AmpliTaqGold (Life Technologies, Austin, Texas, USA) was
performed using primerB (5’-GTTTCCCAGTCACGATC-3’) with 30 cycles; this step was run
in duplicate. The PCR products were purified and eluted in 15 μL using a Zymo DNA Clean
and Concentrator kit (cat n˚ D4013, Zymo Research, USA) to yield enough DNA for the
library preparation.
Sequencing protocol
NGS sequencing was performed at SGB-UAB, Barcelona. dsDNA samples were quantified by
Qubit 2.0 (Life technologies), and libraries were constructed using a Nextera XT DNA sample
preparation kit (Illumina Inc). Samples were sequenced on Illumina MiSeq 2x300; all samples
were multiplexed and distributed within three independent sequencing runs.
NGS data processing
The quality of raw and clean read sequences was assessed using FASTX-Toolkit software, ver-
sion 0.0.14 (Hannon Lab) [25]. The sequenced reads were cleaned by Trimmomatic version
0.32 [26] while the sequencing adaptors and linker contamination were removed. Low-quality
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ends were trimmed using a Phred score average threshold above Q15 over a running window
of four nucleotides. Low-complexity sequences, mostly repetitive sequences that would affect
the performance of downstream procedures in the computational protocol, were then discarded
after estimating a linear model based on Trifonov’s linguistic complexity and the sequence
string-compression ratio. The discrimination criteria for that linear model assumes low com-
plexity scores below the line having a -45˚ slope and crossing data distribution at 5% below the
complexity inflexion point found by the model, which is specific to each sequence set. Finally,
duplicated reads were removed in a subsequent step to speed up the downstream assembly.
Sequence assembly and taxonomic assignment
Clean and filtered MiSeq reads were assembled using as parameters 90% identity over a mini-
mum of 50% of the read total length in CLC Genomics Workbench 4.4 (CLC bio USA, Cam-
bridge, MA) [27]. Afterwards, contigs longer than 100 bp were queried for sequence similarity
using BLASTN and BLASTX (NCBI-BLAST [28]) against the NCBI complete viral genomes
database [29,30], the viral division of the GenBank nucleotide database [31,32], and viral pro-
teins from UniProt [33]. The species nomenclature and classification followed NCBI Taxon-
omy database standards and the basic Baltimore classification. The alignments reported by
BLAST (High-scoring Segment Pairs, HSPs) were required to have an E-value lower than 10−5
and a minimum length of 100 bp to be considered for taxonomical assessment. On the basis of
the best BLAST results and a 90% coverage cut-off, the sequences were classified into their
most likely taxonomic groups of origin.
Phylogenetic analysis
For Anelloviridae, phylogenetic trees were constructed based on the complete ORF1 region
(with 75 reference sequences and a length alignment of 2551 bp), once contigs were properly
aligned and trimmed. All the representative members of this family reported in humans were
included as reference strains. Additionally, we also included some contigs longer than 1,500 bp
that overlapped a large segment of ORF1 or a region upstream for individual trees. We com-
pared each tree with the main tree generated from the reference strains to confirm equivalent
distribution of species. In this manuscript, the following notation criteria were applied to name
sequences on the phylogenetic trees: sequences covering ORF1, partially or not, were assigned to
a number; contigs having some part outside ORF1 were identified with letters. For Hepeviridae,
of the sequences mapped over the genome, we clipped the region that was present in all the
sequence contigs under consideration. Then, the clipped region alignment was refined and
some gaps were manually curated after visual inspection to improve the resulting alignment
score. A reference phylogenetic tree was calculated from an alignment of 7483 bp with 22
known complete genomic sequences (19 of the genotype 3) as previously described [34]. Partial
contig sequences aligning to a given particular region produced an equivalent tree. Those
sequences were manually placed in the main tree according to the corresponding branches posi-
tion on the equivalent trees, yet they are shown on the main reference tree as numbers or letters
next to reference sequence identifier. All the alignments were produced by Geneious 101 as well
as the phylogenetic trees, which were computed using the neighbour-joining method under the
Jukes Cantor model. The robustness of the trees was assessed by bootstrap analysis of 1000 repli-
cates each; finally, the branches are proportional to the corresponding phylogenetic distance.
Ethical statement
The study has been approved by the corresponding ethical committee: ethical committee
on clinical investigation and research projects of the Hospital Universitari Vall D’Hebron
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(N˚ 185; date: 4/2/2011). Serum samples were pooled at the hospital and for this study we do
not have information on the identity of the patients.
Results
Nine libraries, consisting of 62 serum samples (32 of patients with unknown hepatitis, 10 of
known HEV infections and 20 heathy volunteers), were obtained and sequenced using paired-
end 300-base runs on the Illumina MiSeq platform, generating a total of 48 million reads (see
Table 1 for a summary of the sequencing statistics for individual pools). Raw reads were
binned by pool-based library barcodes and quality-filtered, leaving 30.5 million high-quality
reads, which were assembled de novo within each pool subset. The resulting sequence contigs
and singletons were compared to NCBI complete viral genomes, the viral division of the Gen-
Bank nucleotide database, and viral proteins retrieved from UniProt. Most of the viral
sequences detected were related to the Anelloviridae, Astroviridae, Caliciviridae, Hepeviridae,
Flaviviridae and Retroviridae families (Fig 1); those near-to-complete or partial genomes were
characterized and are described in the following sections.
Volunteer samples that were analysed in the Healthy pools, in duplicate, show similar num-
ber of reads, and contigs. Additionally, the same families were found in those replicates, dem-
onstrating that those results are highly consistent across samples (Table 1 and Fig 1).
Hepeviridae
A total of 27 contigs were matched to sequences of the Hepeviridae family. The HEV and Ai
+ImSP pools produced sequences related to this family. A total of 76.1% (5,508 of 7,238 bp) of
the HEV genome was sequenced from the HEV pool, with an average pairwise identity of
85.5% against the genotype 3 HEV (AF082843, Reference sequence genotype 3 ICTV). To
identify the genotypes present in the pools and because metagenomics amplified different
regions of the genome at random, individual phylogenetic trees were computed from contigs
mapping over the same reference genome locations. The individual trees were compared to a
reference species tree based on the reference-genomic sequences. Contigs that produced trees
similar to the reference are marked in Fig 2 using numeric indexes, and information about
each of those contigs is displayed on Table 2. On this table each contig is identified by its name
(Contig ID), the contig length, its alignment identity percent to the homologous sequence
from the blast HSPs, and confidence bootstrap value of the branch where it is placed on the
corresponding phylogenetic tree. We were able to generate phylogenetic trees similar to the
reference for eighteen contigs (the individual trees are available in S1 Supporting Information).
Fifteen contigs from the HEV pool aligned to genotype 3f or closely related genotypes. The
three contigs from the Ai+ImSP pool aligned with genotype 3a.
Anelloviridae
A total of 3,286 contigs matched sequences from the Anelloviridae family. All the pools pro-
duced sequences related to this family; however, the number of contigs was significantly higher
in the pools with signs of hepatitis compared to the healthy pools (Wilcoxon rank-sum test,
p = 0.009) and much more abundant in the Ai+ImSP pool (Fig 1). Contigs completely covering
the ORF1 region of Anelloviridae family—or longer than 1,500 bp and overlapping this region
—were found in the male A (less than 48 years old), female, HEV, and Ai+ImSP pools. Those
particularly long sequences were used to build a phylogenetic tree to obtain a more accurate
characterization of the species (Fig 3 and Table 3). The main members detected were Torque
Teno Viruses (TTV—genus Alphatorquevirus) 1, 5, 10, 11, 13, 16, 18, 19, SEN virus H, Torque
Teno Mini Viruses (TTMV—genus Betatorquevirus) 5, 9 and 18, Torque Teno Midi Viruses
Identification of novel viruses in patients with acute hepatitis of unknown aetiology
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Table 1. Summary of the sequences produced for each pool of serum samples in the sequencing experiment. All read counts correspond to total val-
ues, and the paired-reads real counts are half the values shown in the table. PE: paired-end reads; SE: single-end reads.
Pool ID Number of samples Raw Reads
(PE MiSeq)
Clean Reads
(PE + SE)
Contigs
(after assembly)
Male A 8 5,255,854 3,614,220 + 6,928 43,188
Male B 8 2,669,124 1,769,992 + 4,738 19,000
Female 8 12,029,238 7,470,502 +18,074 83,518
Ai+ImSP 8 6,000,606 3,887,728 + 197,320 5,889
HEV 10 8,145,076 5,769,136 + 2,025 13,060
Healthy A.1 10 3,413,928 1,873,370 + 286 189,820
Healthy A.2 3,588,692 1,796,830 +298 166,167
Healthy B.1 10 3,457,150 2,119,224 +250 227,469
Healthy B.2 3,494,586 1,934,704 + 4 185,359
https://doi.org/10.1371/journal.pone.0185911.t001
Fig 1. Heatmap describing number of contigs identified in each pool after their characterization and
classification into taxonomic groups. Rows correspond to pooled samples whilst columns to families
mapped at least to one sample. Numbers within each cell represent the number of sequences that had at least
a positive BLAST hit to into known species and passed all the selection criteria. The colours range from yellow
to red (low to high abundance respectively); green means that sequences were not detected for that group.
https://doi.org/10.1371/journal.pone.0185911.g001
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(TTMDV—genus Gammatorquevirus) 1, MDJN47, MDJN97, and other unclassified anello-
viruses: TTV P19-3 (KT163917), TTV S72 (KP343839), TTV P1-3 (KT163877), TTV P13-4
(KT163899), TTMV Emory1 (KX810063), TTV S97 (KP343864), TTMV LY3 (JX134046),
TTV S66 (KP343833), TTV S69 (KP343836), TTV S45 (KF545591), TTV P9-6 (KT163891),
TTV S80 (KP343847), and TTV S57 (KP343824). Furthermore, contigs matching to the last
two reference sequences do not belong to the three known genera of Anelloviridae previously
identified in humans; thus, it seems they define a new cluster/genus for this family. Moreover,
60% (19/32) of the longest contigs have less than 80% identity to the already described
sequences from the NCBI database. Table 3 shows the contigs that were considered for this
phylogenetic analysis; each contig is identified by its name (contig ID), sequence length in bp,
alignment identity percent to the homologus sequence from the BLAST HSPs, and confidence
bootstrap value of the branch where it is placed on the corresponding phylogenetic tree (indi-
vidual trees are provided in the S2 Supporting Information). Fewer and shorter contigs were
found in the pools from healthy individuals in comparison with the other pools (median of
300 bp); they correspond to TTV 1, 19 and TTMV 6.
Caliciviridae
A total of 35 contigs between 200 and 654 bp aligned to the Caliciviridae family. They were
found in the male A and B, female and Ai+ImSP pools. No sequences of this family were
Fig 2. Phylogenetic tree of Hepeviridae based on complete genomes, including the main members of genotype 3. Numbers in blank bullets
correspond to contigs identified in the HEV and Ai+ImSP pools (see Table 2); they are located beside the reference sequence where specific individual
alignments of sequenced fragments over the same region in the reference sequences generated an equivalent tree topology (further results available from
S1 Supporting Information). Labels within the square brackets define the species subtype. Small numbers on the tree branches show the bootstrap score
of those branches.
https://doi.org/10.1371/journal.pone.0185911.g002
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detected in healthy volunteer pools. All contigs were assigned to sapovirus Hu/Nagoya/NGY
(AB775659), genogroup 5 strain 2 (GV.2), with identities varying between 97% and 100%.
Those contigs map over several regions of the non-structural protein and major structural pro-
tein, including eleven that aligned to a partial capsid fragment.
Astroviridae
As few as eight contigs between 214 and 493 bp long matched the Astroviridae family. They
were found in the male A (less than 48 years old), female, and Ai+ImSP pools. No sequences of
this family were detected in the healthy-volunteers pools. These contigs correspond to a
recently discovered astrovirus, clade VA strain 3 (VA3, also known as HMO-C) (7 matching
JX857868, 1 matching JX083288), with identities ranging from 97% to 100%.
Flaviviridae
A total of 65 contigs between 219 and 2778 bp matched the Flaviviridae family. They were
found in the female, Ai+ImSP, and healthy B1 and B2 pools. All the sequences aligned to sev-
eral entries of GB virus C from GenBank, with identities between 97% and 100%.
Retroviridae
In this case, 285 contigs between 300 and 1,032 bp were assigned to the Retroviridae family.
They were found in the male B (more than 48 years old), female, and HEV pools and in all
healthy pools. All the sequences matched several entries of human endogenous retrovirus type
K and HCML-ARV with identities greater than 70%.
The raw sequencing data used to perform this analysis along with the FASTQ file are
located in the NCBI Sequence Read Archive; BioProject (PRJNA379441).
Table 2. Summary of similarity searches for those detected from the HEV and Ai+ImSP pools. The first column corresponds to the numbers in the
black bullets shown on some of the branches of the Hepeviridae phylogenetic tree from Fig 2.
Code Pool Contig ID Length %Identity Bootstrap
1 AI+IMSP contig_953 992 91.63 100.0
2 AI+IMSP contig_1893 686 91.40 97.4
3 AI+IMSP contig_3606 412 91.02 84.1
4 HEV contig 3810 573 86.83 60.0
5 HEV contig_2453 1,416 91.05 68.4
6 HEV contig_533 590 90.51 70.0
7 HEV contig_1542 575 89.04 76.7
8 HEV contig 749 541 88.54 51.3
9 HEV contig_6571 1,572 91.35 99.9
10 HEV contig_747 1,415 88.30 74.6
11 HEV contig _3424 1,032 90.31 83.3
12 HEV contig_6979 944 91.58 100.0
13 HEV contig_7146 929 89.26 95.0
14 HEV contig_8370 557 93.33 96.0
15 HEV contig 10460 314 86.29 95.4
16 HEV contig 3914 297 87.21 65.2
17 HEV contig_1444 1,534 87.11 98.3
18 HEV contig 3007 333 89.33 86.7
https://doi.org/10.1371/journal.pone.0185911.t002
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Fig 3. Phylogenetic tree for the Anelloviridae family based on ORF1 region and including only contigs
that fully overlap with that region. Numbers and letters within black bullets refer to contigs longer than
1,500 bp (see Table 3) that partially aligned with ORF1 or with the ORF1 upstream region, respectively. See
Fig 2 for further details about notation used in this tree.
https://doi.org/10.1371/journal.pone.0185911.g003
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Discussion
The aim of this study was to investigate viruses infecting patients diagnosed with acute hepati-
tis. Different groups of patients presenting with acute hepatitis but without serological infec-
tion markers of the most common viral hepatitis were studied to determine possible causal
agents of non-A-E hepatitis. Our findings demonstrate the presence of a high variety of viral
sequences in pools of patients with hepatitis of unknown aetiology.
HEV viruses were detected in two pools (HEV and Ai+ImSP). We found a variety of con-
tigs related to genotype 3f in HEV pools. Genotype 3f has been described in hepatitis outbreaks
in Catalonia [35], Spain [36] and the south of France [37]. This strain has also been related to
swine and wild boar consumption, which can be considered a food-borne and an emerging
zoonotic infection [35,38,39]. Individual samples from the Ai+ImSP pool were re-analysed
afterwards by nPCR, and one patient was identified as HEV-positive in this second round,
Table 3. Summary information for contigs longer than 1,500 bp that were found in the pooled samples and assigned to the Anelloviridae family.
The number and letter codes from the first column (Code) correspond to those in the blank bullets shown on some of the branches of the phylogenetic tree
from Fig 3. Those without codes were placed directly on the tree, as they defined new branches.
Code Sample Contig ID Length (bp) Sequence Name % Identity Bootstrap
Male A contig_3809 2,798 TTV P19-3 92.8 100.0
D Male A contig_1199 1,512 TTV P13-4 69.3 68.0
10 Male A contig_7929 1,875 TCHN-D2/TTV 11 79.2 100.0
12 Female contig_1 1,548 TTV P1-3 92.4 100.0
11 Female contig_129 1,506 TTV S72 79.8 100.0
14 Female contig_16376 1,513 TTMDV MDJN47 68.3 91.9
Female contig_2757 2,142 TTMV 9 76.6 99.0
Female contig_4524 1,977 TTMDV MDJN97 72.1 100.0
1 Female contig_5911 1,500 TJN2/TTV19 88.9 100.0
A Female contig_626 1,503 TTMV 18 89.7 100.0
Female contig_6674 2,381 TTV S69 71.2 97.0
Female contig_818 2,264 TTV P1-3 95.1 99.0
7 Female contig_9035 2,243 JA4 94.0 100.0
4 Female contig_1475 1,899 TCHN-A 87.5 100.0
13 Female contig_1946 1,644 TTMDV1 71.6 100.0
2 Female contig_268 1,951 SENV-H 90.1 100.0
Female contig_311 2,086 TTMDV MDJN47 66.6 89.0
8 Female contig_6533 1,530 TTV10 83.3 100.0
Female contig_7650 1,730 TTV P9-6 69.6 51.0
17 AI+IMSP contig_1199 1,586 TTV S80 66.8 99.8
AI+IMSP contig_793 2,367 TTV 16 90.8 100.0
15 AI+IMSP contig_1013 1,687 TTMDV MDJN47 66.0 95.8
9 AI+IMSP contig_1709 1,832 TTV 10 85.7 100.0
18 AI+IMSP contig_2151 1,985 TTV S97 65.6 79.0
B HEV contig_118 1,781 TTMV Emory1 68.6 68.0
3 HEV contig_2837 1,845 TTV S45 86.6 100.0
HEV contig_125 2,303 TTV S57 70.1 100.0
C HEV contig_2 1,923 TTMV LY3 66.6 79.0
5 HEV contig_236 1,643 TTV TCHN-E 72.0 99.9
6 HEV contig_2366 1,514 TTV P19-3 93.8 100.0
16 HEV contig_506 2,046 TTMV 5 73.7 96.0
E HEV contig_66 1,904 TTV S66 71.9 49.0
https://doi.org/10.1371/journal.pone.0185911.t003
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which would explain the presence of HEV contigs in this pool. Metagenomics approaches
have the advantage of identifying more than one genotype in the pools; this facilitates descrip-
tion of traces of possible multiple infections in a single sample.
We have found at least three different kinds of Anelloviridae contigs: a) contigs that match
previously characterized sequences; b) contigs that are closely related to unclassified
sequences; and, c) contigs poorly related to classified and unclassified sequences (potential
new viruses). The demarcation criteria of the genus establish a cut-off value of 35% nucleic-
acid identity in the ORF1 region. Due to the number of quasispecies discovered in this family
[40], it is difficult to establish a clear cut-off at the species level.
We also describe in this paper viruses that have been previously associated with hepatitis
such as TTV-1, 11, 16 and SEN virus H [14,41]; other viruses have been recently described in
serum samples from HIV patients (P19-3, P13-4, P9-6, P1-3); yet other sets were described in
patients with various conditions, including lymphocytic leukaemia (TTV 10) [42], gingival
periodontitis (TTMV 18) [43], haemophilia (TTMDV MDJN47 and MDJN97) [44] and in
pregnant women whose offspring developed leukaemia and lymphomas (TTV S45, S57, S66,
S69, S72, S80 and S97) [45].
Metagenomics analyses are driving the discovery of new potential sequences in this family;
Bzhalava et al. (2016) described for first time a group of sequences detected from human sam-
ples, spawning a new branch of the Anelloviridae family. We found two contigs (125 and 1199)
falling into this new potential genus of Anelloviridae, yet they have less than 70% of identity to
those sequences, which were described in serum samples from pregnant women. Such results
suggest that there will be more viruses within this family that have not yet been identified.
TTV-1, the first member identified in the Anelloviridae family, was reported in hepatitis
patients in whom no causative agents were detected [12]. This family includes three genera
that have been identified in humans: Alphatorquevirus (TTV), Betatorquevirus (TTMV), and
Gammatorquevirus (TTMDV) [46]. However, the role of those viruses in hepatitis or in other
diseases remains uncertain [14,40,47]. Numerous recent studies have demonstrated a preva-
lence between 5 and 90% in the blood of the general population, depending on the geographic
region [40]. Moreover, the genetic diversity among anelloviruses is far greater than it is within
any other group of ssDNA viruses. The considerable genetic heterogeneity is exemplified by
the large number of highly divergent sequences being identified in this family. There are at
least 41 species infecting humans that are recognized by the ICTV based on the ORF1 region
[46]. Some viruses, such as TTV 1, 12, 13, 16, SEN virus D and H, have been considered poten-
tial causal agents of hepatitis [14,48–50].
Unfortunately, anelloviruses cannot be propagated in vitro due to the lack of compatible
cell systems. However, they have a high in vivo replication capacity. Infection with TTV is
characterized by persistent lifelong viremia in humans, with circulation levels of up to 106
genomic copies/ml in the general population [14,40]. TTV replicates in the liver and is
excreted at high levels in bile and faeces [51]. Additionally, other studies have shown that this
virus does not have a particular tropism [40,52]. Metagenomic analyses have also shown that
TTV is a common finding in several sample types [53]. For that reason, determining the causa-
tive factors of illness can be difficult.
An increased number of contigs aligning to anelloviruses was observed in this study, how-
ever, these findings not necessarily may support the hypothesis that these viruses are the causa-
tive agents. Previous studies have suggested titres of TTV in plasma as an indicator of immune
status [54]. Another study showed that anellovirus load in plasma increases substantially dur-
ing immunosuppressive therapy and in immunocompromised patients [55]. Shotgun sequenc-
ing from plasma samples that were collected over several months post-transplantation also
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revealed that viral loads increased, whereas the bacterial composition remained unchanged
[56].
The results described in this study also show the presence of sapovirus strain GV.2 in all the
pools of patients with clinical hepatitis of unknown aetiology. This strain has been recently
characterized from faecal samples from a suspected foodborne gastroenteritis outbreak in
Japan using a metagenomics sequencing approach [57]. Partial fragments of that virus were
described early from another gastroenteritis outbreak in Italy [58], in river water from Barce-
lona (the same region where this study was conducted) [59], and in wastewater from Japan
[60], suggesting prevalent circulation of this virus around the world. Sapovirus are positive-
sense single-stranded RNA viruses from the family Caliciviridae. Members of this family are
known to cause gastroenteritis with self-limited infections and low mortality rates; severe
infections or serious clinical complications are usually reported in immunocompromised
patients [61]. Further research would be required to analyse the possible pathogenic role of
sapovirus GV.2 in our study.
Few contigs of the Astroviridae family were detected in this work. Astrovirus VA3 was iden-
tified in most of the pools of hepatitis of unknown aetiology. However, those contigs were less
abundant and shorter than the sapovirus contigs. The first description of astrovirus VA3 was
from the stool of paediatric patients with diarrhoea from India [62], and it was later completely
sequenced [63]. This virus has also been described in stools from southern China [64], Kenya,
and the Gambia [65]. However, the role of this virus in health and disease remain largely
unknown.
The potential pathogenic role of sapovirus GV.2 and astrovirus VA3 in blood remains still
uncertain. Although astroviruses and sapoviruses are considered gastrointestinal pathogens,
viral RNA and infectious particles have been recovered from extraintestinal organs in both ani-
mals and humans. Examples in animals implicate astroviruses as the cause of hepatitis in
ducks [66] and the isolation of murine astroviruses in mouse liver [67]. With respect to sapo-
virus less information is available; an isolation of sapovirus in a liver of a spotted hyena [68].
Our results suggest that the presence of these viruses in pools from patients with non A-to-E
hepatitis, including the AI+ImSp pool, merits further research, since there is no previous evi-
dence relating those viruses to hepatitis.
GB virus C, also known as pegivirus or hepatitis G virus, is a human virus of the Flaviviridae
family that is structurally and epidemiologically closest to hepatitis C virus [13]. Most GBV-C
infections appear to be asymptomatic, transient, and self-limiting, with slight or no elevation
of ALT levels. Those infections are rarely identified and very difficult to evaluate. The role of
GBV-C in the aetiology of hepatitis has not been fully established [69]. Moreover, it is com-
monly reported in metagenomics studies [53], suggesting its limited role in the development
of illness, including hepatitis. We have detected this virus in one healthy pool and in a hepatitis
pool; our results support the hypothesis that this species may be widely distributed within the
population.
Human endogenous retroviruses (HERVs) are remnants of germ-line retrovirus integration
and are considered functionally defective [70]. They have been described in metagenomics
studies at high levels [55,70] without association with any particular pathology [71]. Our find-
ings support previous results pointing out that this virus is present in healthy people.
It is important to recognize that the use of serum samples to describe the virome may have
some minor limitations as a decreased sensitivity to detect integrated proviruses (e.g. HIV-1),
episomal viruses (e.g. herpesviruses) [72]. Furthermore, giant viruses may also be under-repre-
sented due to the filtration process [73]. However, serum samples predominantly contain host
DNA which can also affect the sensitivity of viral detection [74]; if host and viral NA cannot be
easily separated, the resulting fraction of viral sequences relative to the host DNA would be
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extremely low [53]. Pretreatments protocols for viral enrichment have to be taken into consid-
eration in order to get a better approximation to the whole virome and the interaction between
virus population in future studies.
Conclusions
In summary, metagenomics was applied in this study to detect a broad spectrum of viral spe-
cies based on sequences found in pooled samples, including HEV in pools of patients with
confirmed HEV; these samples allowed the characterization of the most prevalent genotypes.
Additionally, we were able to identify a diverse population of anelloviruses, including novel
undescribed sequences, in patients with acute hepatitis of unknown aetiology. Furthermore,
sapovirus GV.2 and astrovirus VA3, viruses recently reported as cause of gastroenteritis, were
also found exclusively in those pools. We did not attempt to determine causality or to describe
epidemiologic results; our purpose was to characterize the virome of patients diagnosed with
hepatitis to describe new potential causal agents. The role of these viruses as possible causal
agents of hepatitis of unknown aetiology remains open to further studies. Finally, reproducibil-
ity between replicates in the pools of healthy volunteers supports the consideration of the
metagenomics as a robust detection method for viral species. Metagenomics analyses offer
unprecedented possibilities for diagnostics, characterization and identification of possible co-
infections of rare and novel viruses that will be relevant to understanding the aetiology of cur-
rent pathologies without known causative agents.
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